Impact Factor 2021: 3.041 (@Clarivate Analytics)
5-Year Impact Factor: 2.776 (@Clarivate Analytics)
Immediacy Index: 0.927
Impact Factor Rank: 10/24, Q2 (Tropical Medicine)
  • Users Online: 615
  • Print this page
  • Email this page
This article has been cited by
1Combined Amoebicidal Effect of Atorvastatin and Commercial Eye Drops against Acanthamoeba castellanii Neff: In Vitro Assay Based on Mixture Design
Ines Sifaoui,Eulalia Capote Yanes,María Reyes-Batlle,Rubén L. Rodríguez-Expósito,José E. Piñero,Jacob Lorenzo-Morales
2Fluvastatin and atorvastatin induce programmed cell death in the brain eating amoeba Naegleria fowleri
Aitor Rizo-Liendo,Ines Sifaoui,Iñigo Arberas-Jiménez,María Reyes-Batlle,José E. Piñero,Jacob Lorenzo-Morales
Biomedicine & Pharmacotherapy.2020;130(3)110583
3The type 2 statins, cerivastatin, rosuvastatin and pitavastatin eliminate Naegleria fowleri at low concentrations and by induction of programmed cell death (PCD)
Aitor Rizo-Liendo,Iñigo Arberas-Jiménez,Ines Sifaoui,María Reyes-Batlle,José E. Piñero,Jacob Lorenzo-Morales
Bioorganic Chemistry.2021;110(3)104784
4Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs
Brian Shing,Mina Balen,James H. McKerrow,Anjan Debnath
Expert Review of Anti-infective Therapy.2021;19(11)1427
5In Vitro Activity of Statins against Naegleria fowleri
Aitor Rizo-Liendo,Ines Sifaoui,María Reyes-Batlle,Olfa Chiboub,Rubén L. Rodríguez-Expósito,Carlos J. Bethencourt-Estrella,Desirée San Nicolás-Hernández,Edyta B. Hendiger,Atteneri López-Arencibia,Pedro Rocha-Cabrera,José E. Piñero,Jacob Lorenzo-Morales
6Joining forces: Leveraging novel combination therapies to combat infections with eukaryotic pathogens
Rachel E. Ham,Lesly A. Temesvari,Laura J. Knoll
PLOS Pathogens.2020;16(12)e1009081